GPCR/G protein


All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-
B7689 (±)-SLV 319Summary: CB1 receptor antagonist,potent and selective -
B7690 Tegaserod maleateSummary: Partial agonist of 5-HT4 -
B7691 MEDICA 16Summary: Free fatty acid 1 (FFA1/GPR40) receptor agonist -
B7696 GW 627368Summary: prostanoid EP4 receptor antagonist -
B7715 ML 00253764 hydrochlorideSummary: melanocortin MC4 receptor antagonist -
B7721 MA 2029Summary: motilin receptor antagonist,potent and selective -
B7723 R 1485 dihydrochlorideSummary: 5-HT6 antagonist,selective and high affinity -
B7729 DR 4485 hydrochlorideSummary: 5-HT7 antagonist -
B7730 TC-G 1000Summary: α2D-adrenoceptor agonist -
B7735 AS 2034178Summary: GPR40 agonist

